Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
23.04
+1.11 (5.06%)
At close: Jan 21, 2025, 4:00 PM
23.00
-0.04 (-0.17%)
After-hours: Jan 21, 2025, 5:08 PM EST

Denali Therapeutics Market Cap

Denali Therapeutics has a market cap or net worth of $3.32 billion as of January 21, 2025. Its market cap has increased by 18.02% in one year.

Market Cap
3.32B
Enterprise Value
2.09B
1-Year Change
18.02%
Ranking
Category
Stock Price
$23.04

Market Cap Chart

Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $3.32B, an increase of 75.71%. That is a compound annual growth rate of 8.24%.

History

DateMarket Cap% Change
Jan 17, 20253.16B7.61%
Dec 31, 20242.93B-1.10%
Dec 29, 20232.97B-21.48%
Dec 30, 20223.78B-30.66%
Dec 31, 20215.45B-45.77%
Dec 31, 202010.04B500.43%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 653.46B
UnitedHealth Group 469.12B
Johnson & Johnson 353.99B
Novo Nordisk 341.33B
AbbVie 303.17B
Merck & Co. 247.70B
Thermo Fisher Scientific 214.07B
Intuitive Surgical 211.09B
Market Cap Rankings